Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Pediatr Blood Cancer. 2021 Dec;68(12):e29335. doi: 10.1002/pbc.29335. Epub 2021 Sep 14.
Many childhood cancersurvivors experience at least one late effect of treatment, and both late effects and persistent cancer-related worry can negatively impact quality of life in survivorship. Little is known about the prevalence or impact of parental worry about late effects early in treatment. This study evaluated parental perceived likelihood, impact, and worry about late effects of childhood cancer.
We surveyed 96 parents of pediatric cancer patients at Dana-Farber/Boston Children's Cancer and Blood Disorders Center within a year of diagnosis. Parents were asked about their experiences with late effects communication, general worry about late effects, and specific late effect worries.
Most (96%) parents valued information about late effects, and 93% considered late effects in their treatment decision-making. Yet, 24% could not recall receiving any information about late effects, and only 51% felt well prepared for potential late effects. Though only 20% of parents considered their child at high risk of experiencing late effects, 61% were extremely/very worried about late effects. Those who felt their child was at high risk of experiencing late effects were more likely to worry (OR = 4.7, P = 0.02).
Many parents feel inadequately informed about late effects of cancer treatment, and only one-fifth of parents consider late effects to be likely for their child. However, a majority of parents worry about late effects, including ones they think their child is unlikely to experience. Although some worry is anticipated, disproportionate worry may be mitigated by addressing both educational shortfalls and emotional concerns.
许多儿童癌症幸存者至少经历过一种治疗后的晚期效应,晚期效应和持续的癌症相关担忧都会对生存者的生活质量产生负面影响。对于治疗早期父母对晚期效应的担忧的发生率和影响知之甚少。本研究评估了父母对儿童癌症晚期效应的感知可能性、影响和担忧。
我们在诊断后一年内对达纳-法伯/波士顿儿童癌症和血液疾病中心的 96 名儿科癌症患者的父母进行了调查。父母被问及他们对晚期效应沟通、对晚期效应的一般担忧以及对特定晚期效应担忧的经历。
大多数(96%)父母重视有关晚期效应的信息,93%的父母在治疗决策中考虑了晚期效应。然而,24%的父母无法回忆起收到过任何关于晚期效应的信息,只有 51%的父母觉得自己对潜在的晚期效应有充分的准备。尽管只有 20%的父母认为他们的孩子有发生晚期效应的高风险,但 61%的父母非常/非常担心晚期效应。那些认为自己的孩子有发生晚期效应高风险的父母更有可能担心(OR=4.7,P=0.02)。
许多父母觉得自己对癌症治疗的晚期效应了解不足,只有五分之一的父母认为晚期效应可能发生在自己的孩子身上。然而,大多数父母都担心晚期效应,包括他们认为自己的孩子不太可能经历的晚期效应。虽然预期会有一些担忧,但通过解决教育方面的不足和情绪问题,可以减轻不成比例的担忧。